Skip to main content
logo
Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.450
+0.020 (0.58%)
At close: Jun 12, 2026, 4:00 PM EDT
3.450
0.00 (0.01%)
After-hours: Jun 12, 2026, 7:09 PM EDT

Niagen Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
275507411107125255
Market Cap Growth
-68.16%23.47%282.96%-14.41%-50.83%-14.22%
Enterprise Value
211.53444.01367.6282.47108.39230.73
Last Close Price
3.456.365.311.431.683.74
PE Ratio
16.4331.8048.27---
Forward PE
16.5327.8150.28---
PS Ratio
2.113.924.121.281.743.78
PB Ratio
3.346.628.913.774.378.03
P/FCF Ratio
67.0638.3734.3715.39--
P/OCF Ratio
62.2037.5433.9115.07--
EV/Sales Ratio
1.623.433.690.991.503.42
EV/EBITDA Ratio
17.6633.9043.05---
EV/EBIT Ratio
19.0636.0647.58---
EV/FCF Ratio
51.5233.6130.7711.83--
Debt / Equity Ratio
0.020.020.040.090.120.13
Debt / EBITDA Ratio
0.260.220.31---
Debt / FCF Ratio
0.630.210.220.47--
Net Debt / Equity Ratio
-0.78-0.81-0.91-0.84-0.56-0.74
Net Debt / EBITDA Ratio
-6.40-4.73-4.925.260.920.91
Net Debt / FCF Ratio
-15.58-4.69-3.52-3.451.050.96
Asset Turnover
1.181.481.621.531.291.40
Inventory Turnover
2.103.123.212.252.072.05
Quick Ratio
3.493.742.921.581.621.90
Current Ratio
4.614.863.572.402.612.78
Return on Equity (ROE)
18.90%25.00%25.97%-17.29%-54.77%-112.68%
Return on Assets (ROA)
7.72%13.39%12.15%-10.27%-33.29%-56.29%
Return on Invested Capital (ROIC)
34.08%77.00%98.62%-45.68%-127.08%-274.10%
Return on Capital Employed (ROCE)
10.24%18.00%18.25%-15.88%-48.75%-87.18%
Earnings Yield
6.77%3.14%2.07%---
FCF Yield
1.49%2.61%2.91%6.50%--
Buyback Yield / Dilution
-7.04%-9.36%-4.19%-7.54%-3.79%-10.02%
Total Shareholder Return
-7.04%-9.36%-4.19%-7.54%-3.79%-10.02%
SEC Filings: 10-K · 10-Q